Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Post-menopausal bleeding.

H Wagman

    Bailliere'S Clinical Obstetrics and Gynaecology
    |June 1, 1988
    PubMed
    Summary

    Postmenopausal bleeding (PMB) can indicate a 20% risk of genital tract malignancy. Early diagnosis of uterine adenocarcinoma, a treatable condition, is crucial. Other causes of PMB are typically minor and manageable.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Value of preoperative pregnancy test in risk management.

    Lancet (London, England)·1996
    Same author

    Caesarean section rates.

    Lancet (London, England)·1993
    Same author

    External cephalic version under tocolysis.

    The British journal of clinical practice·1984
    Same author

    Oxytocin challenge test as an out patient procedure.

    The British journal of clinical practice·1984
    Same author

    Management of breech presentation.

    British journal of hospital medicine·1983
    Same author

    Laparoscopy in diagnosis of pelvic tuberculosis.

    Lancet (London, England)·1979

    Area of Science:

    • Gynecology
    • Oncology

    Background:

    • Postmenopausal bleeding (PMB) is a common gynecological symptom.
    • PMB is associated with a significant incidence of malignancy in the genital tract, estimated at 20%.

    Purpose of the Study:

    • To emphasize the importance of excluding uterine adenocarcinoma in patients presenting with PMB.
    • To highlight the favorable prognosis of early-diagnosed uterine adenocarcinoma.

    Main Methods:

    • Clinical evaluation of patients with postmenopausal bleeding.
    • Diagnostic workup to rule out gynecological malignancies, particularly uterine adenocarcinoma.

    Main Results:

    • A 20% incidence of malignancy is linked to PMB.
    • Uterine adenocarcinoma, if diagnosed early, has a good prognosis.
    • Most other causes of PMB are minor and manageable.

    Conclusions:

    • Thorough investigation is essential for all cases of PMB to exclude malignancy.
    • Prompt diagnosis and management of uterine adenocarcinoma improve patient outcomes.
    • Non-malignant causes of PMB generally have a favorable prognosis with appropriate treatment.

    Related Experiment Videos